National Allergy Council

The Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia (A&AA), as the leading medical and patient organisations for allergy in Australia, are partners in the National Allergy Council, which was launched on Wednesday 31st  August 2022 during the ASCIA 2022 Conference week in Melbourne.  The National Allergy Centre of Excellence (NACE) was launched at the same time.

The National Allergy Council continues to implement the National Allergy Strategy, which was developed by ASCIA and A&AA, in collaboration with key stakeholder organisations, and launched in August 2015.

The National Allergy Council has received funding from the Australian Government Department of Health from 1 July 2022 to 30 June 2026, to progress the implementation of the National Allergy Strategy in response to the Parliamentary Inquiry into Allergies and Anaphylaxis which led to the Walking the allergy tightrope report. This funding also includes funding provision for the National Allergy Council partner organisations - ASCIA and A&AA.

Development of the National Allergy Strategy

While funding from the Australian Government Department of Health has supported implementation since 2015, development of the National Allergy Strategy, including two Allergy Summits was funded by unrestricted education grants obtained by ASCIA. 

In September 2019 a Parliamentary Inquiry into Allergies and Anaphylaxis was announced, and hearings were held frrom October 2019 to February 2020. In May 2020 a report on the Inquiry was published, "Walking the Allergy Tightrope - Addressing the rise in allergies and anaphylaxis in Australia". The report is available here

The Australian Government's response to the Walking the allergy tightrope report was tabled in Parliament in April 2023. For information about National Allergy Council projects visit https://nationalallergycouncil.org.au/

Content updated May 2024